Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma

Benjamin R. Kipp(Mayo Clinic), Jesse S. Voss, Sarah E. Kerr, Emily G. Barr Fritcher, Rondell P. Graham, Lizhi Zhang, W. Edward Highsmith, Jun Zhang, Lewis R. Roberts(Mayo Clinic), Gregory J. Gores(Mayo Clinic), Kevin C. Halling

Human Pathology

April 12, 2012

10.1016/j.humpath.2011.12.007

Cited by 240

Abstract

Related Papers

<i>IDH1</i>and<i>IDH2</i>Mutations in Gliomas

Hai Yan, D. Williams Parsons, Genglin Jin et al.|New England Journal of Medicine|2009|5.9k

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

D. Williams Parsons, Siân Jones, Xiaosong Zhang et al.|Science|2008|5.8k

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang, David W. White, Stefan Größ et al.|Nature|2009|4.1k

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

Patrick S. Ward, Jay Patel, David R. Wise et al.|Cancer Cell|2010|2k

Analysis of the IDH1 codon 132 mutation in brain tumors

Jörg Balß, Jochen Meyer, Wolf Mueller et al.|Acta Neuropathologica|2008|1k